DalsnaFinance › IPOs › Avenue Therapeutics › IPO
AVENUE THERAPEUTICS, INC. completed its initial public offering on NASDAQ on June 27, 2017, pricing at $6.00 a share.
| Ticker | ATXI |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 27, 2017 |
| Offering price | $6.00 |
| Shares offered | 5,500,000 |
| Total raised | $33M |
AVENUE THERAPEUTICS, INC. sold 5,500,000 shares at $6.00 each on NASDAQ. Multiplied out, that is $33 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $33 million total recorded for the deal.
AVENUE THERAPEUTICS, INC. — quote, profile and latest news →
Source: SEC EDGAR filings for AVENUE THERAPEUTICS, INC.. This page is general information, not investment advice.